Cargando…
Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression
Adoptive cell therapies (ACTs) using tumor-reactive T cells have shown clinical benefit and potential for cancer treatment. While the majority of the current ACT are focused on using CD8(+) cytotoxic T lymphocytes (CTL), others have shown that the presence of tumor-reactive CD4(+) T helper (Th) cell...
Autores principales: | Li, Kunyu, Baird, Margaret, Yang, Jianping, Jackson, Chris, Ronchese, Franca, Young, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007627/ https://www.ncbi.nlm.nih.gov/pubmed/27588200 http://dx.doi.org/10.1038/cti.2016.46 |
Ejemplares similares
-
Adoptive cell therapy with CD4(+) T helper 1 cells and CD8(+) cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes
por: Li, Kunyu, et al.
Publicado: (2017) -
Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL
Publicado: (1996) -
CD4 CTL, a Cytotoxic Subset of CD4(+) T Cells, Their Differentiation and Function
por: Takeuchi, Arata, et al.
Publicado: (2017) -
Overcoming CD4 deficiency to induce long-lived memory CD8(+ )CTL
por: Oh, SangKon, et al.
Publicado: (2006) -
Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation
por: Xiao, Zhengguo, et al.
Publicado: (2007)